Preston Robert Tisch Brain Tumor Center at Duke

05/26/2026

Brain tumor patients rely on continued research, innovation, and access to advanced care.

Your support helps fund critical research, expand clinical trials, and bring new treatment options to patients. Consider making a gift, sharing this post, or reposting to help raise awareness and support progress in brain tumor research.

https://tischbraintumorcenter.duke.edu/givetoday

05/22/2026

About 90,000 people are diagnosed with a brain tumor each year in the United States, underscoring the significant and ongoing impact of this disease.

At the Preston Robert Tisch Brain Tumor Center at Duke, our teams are working to advance research, expand clinical trials, and develop innovative therapies to improve outcomes for patients and families. Through continued investment and collaboration, we are driving progress toward more effective treatments and a cure.

05/21/2026

Brain metastases are significantly more common than primary brain tumors and are an increasingly important area of focus in cancer care. As treatments improve and patients live longer, the likelihood of cancer spreading to the brain has also increased.

Almost all cancers have the potential to spread to the brain or spine, with lung, breast, prostate, kidney, melanoma, ovarian, and thyroid cancers among the most common sources. This underscores the need for specialized, multidisciplinary care and continued research to better understand and treat metastatic disease.

At the Duke Center for Brain and Spine Metastasis, our teams are advancing research and expanding treatment approaches to improve outcomes for patients facing brain metastases.

05/20/2026

Brain tumors are the leading cause of cancer-related death in children, underscoring the urgent need for continued research and specialized care.

Learn more about our pediatric neuro-oncology program and ongoing efforts to improve outcomes for children and families: https://tischbraintumorcenter.duke.edu/pediatric-neuro-oncology-program

Discover expert care for children with brain tumors at Duke’s Pediatric Neuro-Oncology Program. Leading research, treatment & family support.

05/19/2026

May is National Cancer Research Month, a time to recognize the critical role research plays in advancing care and improving outcomes for patients.

At the Preston Robert Tisch Brain Tumor Center at Duke, research is central to our mission. Our teams are working to better understand brain tumor biology, develop more effective and targeted therapies, and expand access to clinical trials. These efforts are essential to improving patient outcomes and moving the field forward.

Continued investment in research is key to accelerating discoveries and bringing new treatment options to patients and families.

05/15/2026

Thank you to everyone who made Angels Among Us 2026 such a meaningful day for the brain tumor community.

This year, nearly 5,000 participants and 279 teams came together in support of the Preston Robert Tisch Brain Tumor Center at Duke, helping raise $2,880,388 to advance brain tumor research and patient care.

Angels Among Us continues to reflect the strength of this community and the shared commitment to improving outcomes for patients and families affected by brain tumors. The support generated through this event helps drive research initiatives, clinical care, supportive care programs, and future treatment advancements at Duke.

We are grateful to every participant, donor, volunteer, sponsor, patient, survivor, caregiver, and supporter who contributed to this year’s event.

05/14/2026

Advancing care for brain tumor patients takes research, innovation, and community support.

Your gift helps drive new discoveries, expand treatment options, and provide hope to patients and families at every stage of their journey. Consider donating, sharing, or reposting to help make an impact.

05/13/2026

The Preston Robert Tisch Brain Tumor Center at Duke is committed to providing hope and empowering patients through unparalleled care, research, and education.

Bringing together leading clinicians, researchers, and support teams, the Center delivers comprehensive, multidisciplinary care while advancing innovative treatments and working toward a cure for brain tumors.

05/12/2026

Duke is advancing the future of cancer care with the addition of its own proton therapy machine, expected to begin treating patients in 2029.

This leading-edge technology will expand access to highly precise radiation treatment, with the capacity to treat more than 800 patients each year. This milestone represents a significant step forward in delivering innovative, patient-centered care.

05/11/2026

Brain tumor symptoms can vary widely depending on the size, type, and location of the tumor, but recognizing early warning signs is critical.

Persistent headaches, new-onset seizures, memory changes, vision problems, weakness or numbness, and balance issues may all be signs that warrant medical attention. These symptoms can develop gradually or appear suddenly, and should not be ignored, especially if they are new or worsening.

Early evaluation and diagnosis can make a meaningful difference in treatment options and outcomes. If you or someone you know is experiencing these symptoms, contact our team or learn more at https://tischbraintumorcenter.duke.edu/ or call 919.684.5301.